Finally, OPRL1 agonists, administered in CeA, could inhibit fear consolidation in mice and a DNA polymorphism within the human OPRL1 gene was associated with PTSD, altered fear learning and amygdala-insula co-activation (Andero et al., 2013). This evidence concerns the gene OPRL1 and post-traumatic stress disorder.